Overview

Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Status:
Terminated

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

Summary

This research is being done to evaluate the effect of glucagon-like peptide-1 (GLP-1, a naturally occurring hormone) on insulin release and to examine whether there is extra insulin release when GLP-1 is not allowed to be rapidly inactivated.

Phase:

Phase 2

Details

Lead Sponsor:

Johns Hopkins University

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Glucagon-Like Peptide 1
Sitagliptin Phosphate